US 11358931
Selective androgen receptor modulators (SARMs) and uses thereof
granted A61KA61K31/401A61K31/402
Quick answer
US patent 11358931 (Selective androgen receptor modulators (SARMs) and uses thereof) held by Ligand Pharmaceuticals Incorporated expires Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ligand Pharmaceuticals Incorporated
- Grant date
- Tue Jun 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/401, A61K31/402, A61K31/5383, A61K45/06